Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians

Increased COVID‐19 vaccine hesitancy presents a major hurdle in global efforts to contain the COVID‐19 pandemic. This study was designed to estimate the prevalence of adverse events after the first dose of the Covishield (AstraZeneca) vaccine among physicians in Bangladesh. A cross‐sectional study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Md. Anwarul Azim, Lutfor, Afzalunnessa Binte, Rabbi, Ahbab Mohammad Fazle, Alam, A. B. M. Muksudul, Rahman, Mizanur, Saha, Narayan, Campbell, Michael H., Haque, Mainul, Nessa, Kamrun, Khondoker, Mohib Ullah, Das, Tapas Ranjan, Rahman, Sayeeda, Jahan, Fauzia, Mashreky, Saidur Rahman, Wahab, Abrar, Siddiqui, Md. Tosaddeque Hossain, Hinkson‐Lacorbiniere, Karisha, Ivy, Roksana, Islam, Rezaul, Haider, Yusuf, Omar, Eliza, Ahmed, S. M. Moslehuddin, Reza, A. M. Selim, Daud, A. K. M., Choudhury, Muiz Uddin Ahmed, Hossain, Md. Abed, Pappu, Abdul Matin, Jahan, Nusrat, Razzaque, Mohammed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111157/
https://www.ncbi.nlm.nih.gov/pubmed/35601057
http://dx.doi.org/10.1096/fba.2021-00158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111157/
https://www.ncbi.nlm.nih.gov/pubmed/35601057
http://dx.doi.org/10.1096/fba.2021-00158

Ejemplares similares